Trials / Withdrawn
WithdrawnNCT02758067
Comparison of the Effectiveness of Brexpiprazole With That of Risperidone
Interventional, Randomised, Double-blind, Parallel-group, Active-comparator, Flexible-dose Study to Compare the Effectiveness of Brexpiprazole to That of Risperidone in Adult Patients With Schizophrenia
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To demonstrate that the effectiveness of brexpiprazole (2-4 mg/day) on quality of life is non-inferior to that of risperidone (4-6 mg/day) in adult patients with schizophrenia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | brexpiprazole | 2- 4 mg/day, tablets, oral, 28-weeks |
| DRUG | risperidone | 4-6 mg/day, tablets, oral, 28-weeks |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2016-06-01
- First posted
- 2016-05-02
- Last updated
- 2016-08-01
Source: ClinicalTrials.gov record NCT02758067. Inclusion in this directory is not an endorsement.